Q: There hasn't been an update on this company for some time. Can you provide EPS and Revenue growth forecasts going forward. It has trended down since mid last year and wondering if more patience is warranted. Thank you.
5i Research Answer:
Revenues for 2025 are expected to grow by 53.8% and EPS is expected to grow by 28.3%. CPH has been trending down over the last 12 months but remains up 39% with a valuation at 14.3X forward earnings. The healthcare sector has been unloved this year as well, so the weakness is not 'surprising'. Between the growth and valuation, we don't see an outright reason to sell here and would give it another quarter to see how things are progressing.